(MENAFN- PR Newswire) PORT WASHINGTON, N.Y., Oct. 3, 2023 /PRNewswire/ -- EQUASHIELD®, a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, is thrilled to announce that ...
TEL AVIV, April 17 (Reuters) - Israeli medical device maker Equashield expects its sales to grow by more than 60 percent a year as more hospitals invest in its sealed syringes to protect healthcare ...
Equashield (http://www.equashield.com), the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, today announced that The Journal of ...
New PP&P State of Pharmacy Compounding report shows EQUASHIELD® now accounts for 44% of CSTDs in use for hazardous drug preparation PORT WASHINGTON, N.Y., May 8, 2026 /PRNewswire/ -- In a healthcare ...
It’s been said that hospitals are a great place to get sick – not for those who are already ill (although they, too, risk exposure to all sorts of germs and viruses during their stay), but for the ...
Study Finds Equashield is One of Only Two Truly Closed Systems as Defined by Original NIOSH Protocol
University of North Carolina's Eshelman School of Pharmacy studypublished in the Journal of Oncology Pharmacy Practice Equashield (equashield.com), a leading provider of Closed System Transfer Devices ...
PORT WASHINGTON, N.Y., Dec. 3, 2024 /PRNewswire/ -- EQUASHIELD ®, a leader in protecting healthcare workers through innovative compounding solutions and their closed system transfer device (CSTD), is ...
Equashield II Covers the Most Routes of Exposure; First Product to Prevent Contamination of Syringe Plungers by Hazardous Drugs "We are proud to unveil our second generation, market-leading solution, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results